Tonix Pharmaceuticals Holding Corp.
TNXP
$12.83
-$0.33-2.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.44% | -138.84% | -112.19% | -125.22% | 64.11% |
| Total Depreciation and Amortization | 28.16% | 12.58% | -1.61% | -54.36% | -46.63% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | 100.00% | -100.00% |
| Total Other Non-Cash Items | -59.28% | -33.76% | 211.48% | 63.20% | -91.16% |
| Change in Net Operating Assets | -161.57% | -41.65% | -12.22% | 109.30% | 53.89% |
| Cash from Operations | -184.79% | -155.25% | -171.02% | -53.09% | -49.54% |
| Capital Expenditure | -11.39% | -28,100.00% | -62,366.67% | -10,588.89% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.88% | -28,100.00% | -33,933.33% | -10,588.89% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | 140.26% | -67.63% | -21.54% | 113.43% | 15.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.40% | 70.22% | 8.98% | -33.74% | 89.65% |
| Cash from Financing | 204.78% | -59.21% | -30.55% | 121.10% | 56.48% |
| Foreign Exchange rate Adjustments | -1,500.00% | 166.67% | -158.33% | 76.47% | -500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.09% | -172.25% | -73.84% | 170.43% | -120.64% |